Stocksigma LogoStocksigma Logo

Fredun Pharmaceuticals Acquires 26% Stake in ₹300 Crore-Valued Goodman Vetcare

Fredun Pharmaceuticals acquired a 26% stake in Goodman Vetcare, valued at ₹300 crore, strengthening its presence in animal health and veterinary retail

Fredun Pharmaceuticals Acquires 26% Stake in ₹300 Crore-Valued Goodman Vetcare

Fredun Pharmaceuticals Ltd · Press Release · 22 Sept 2026, 2:50 pm

Fredun Pharmaceuticals Acquires 26% Stake in ₹300 Crore-Valued Goodman Vetcare Fredun Pharmaceuticals acquired a 26% stake in Goodman Vetcare, valued at ₹300 crore, strengthening its presence in animal health and veterinary retail. Goodman Vetcare's revenue grew at a 30% annual rate from ₹14.1 crore in FY24 to ₹23.6 crore in FY26. It targets revenues of ~₹40 crore in FY27, ~₹56 crore in FY28, and ~₹100 crore by FY31 via a PAN-India retail expansion of eight new stores across three cities. For FY26, Fredun reported revenue of ₹639.12 crore, EBITDA of ₹94.79 crore, and PAT of ₹33.21 crore.

Original exchange filing (PDF)

More announcements from Fredun Pharmaceuticals Ltd

All Fredun Pharmaceuticals Ltd announcements